Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

University of Toronto

$135,000.00

Characterizing the role of the novel PAQosome chaperone in Proteostasis: A Structural and Functional study

EF 2021-22

Résumé
Molecular chaperons are essential for protein homeostasis in order for the cell to function properly. Chaperones carry out a multitude of activities. They can, for example, facilitate the proper folding of newly synthesized proteins or can promote the assembly of pre-existing proteins. Chaperones have also been implicated in facilitating protein degradation and in enabling protein translocation across membranes. The Houry group identified a novel chaperone complex of about 1 MDa that they named the PAQosome. The PAQosome was found to promote the assembly of critical cellular complexes. It also acts as a platform for other molecular chaperones, such as Hsp90 and Hsp70, to act on substrates. Many of these substrates are polymerases like RNA Polymerase II and kinases like PIKK family members, including mTOR. The PAQosome was found to be upregulated in cancer cells and is considered a novel anticancer drug target. However, currently, there is no detailed understanding of the mechanism of function of this novel chaperone complex. As a postdoctoral fellow in the Houry group, I will use my expertise in cryo-electron microscopy to determine the assembly pathway of the PAQosome consisting of 12 subunits. In parallel, I will be learning X-ray crystallography, protein biochemistry and cell biology as I work on this project to understand the molecular basis of the activity of the PAQosome. Furthermore, several inhibitors of the PAQosome have been identified by the group, and others have been reported in the literature. I will work on assessing the activity of these inhibitors and determine the inhibitor-bound PAQosome structure. My postdoctoral training in the houry group will be a critical step towards subsequently securing an independent academic position. Furthermore, by identifying novel anticancer compounds targeting the PAQosome, the project will have a direct future impact on improving the health outcomes of cancer patients.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
455083
Name
Razi Aida
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Characterizing the role of the novel PAQosome chaperone in Proteostasis: A Structural and Functional study
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Cancer; Cancer Drug; Client Proteins; Cryo Electron Microscopy; Drug Delivery; Heat Shock Protein; Kinase; Paqosome
Abstract
Molecular chaperons are essential for protein homeostasis in order for the cell to function properly. Chaperones carry out a multitude of activities. They can, for example, facilitate the proper folding of newly synthesized proteins or can promote the assembly of pre-existing proteins. Chaperones have also been implicated in facilitating protein degradation and in enabling protein translocation across membranes. The Houry group identified a novel chaperone complex of about 1 MDa that they named the PAQosome. The PAQosome was found to promote the assembly of critical cellular complexes. It also acts as a platform for other molecular chaperones, such as Hsp90 and Hsp70, to act on substrates. Many of these substrates are polymerases like RNA Polymerase II and kinases like PIKK family members, including mTOR. The PAQosome was found to be upregulated in cancer cells and is considered a novel anticancer drug target. However, currently, there is no detailed understanding of the mechanism of function of this novel chaperone complex. As a postdoctoral fellow in the Houry group, I will use my expertise in cryo-electron microscopy to determine the assembly pathway of the PAQosome consisting of 12 subunits. In parallel, I will be learning X-ray crystallography, protein biochemistry and cell biology as I work on this project to understand the molecular basis of the activity of the PAQosome. Furthermore, several inhibitors of the PAQosome have been identified by the group, and others have been reported in the literature. I will work on assessing the activity of these inhibitors and determine the inhibitor-bound PAQosome structure. My postdoctoral training in the houry group will be a critical step towards subsequently securing an independent academic position. Furthermore, by identifying novel anticancer compounds targeting the PAQosome, the project will have a direct future impact on improving the health outcomes of cancer patients.
Competitiondate
202110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Razi, Aida
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~